00000000|MMI|320.74|Portugal|C0032729|[geoa]|["PO"-tx-18-"PO"-noun-0,"PO"-tx-6-"PO"-noun-0,"PO"-tx-5-"PO"-noun-0,"PO"-tx-4-"PO"-noun-0,"PO"-tx-3-"PO"-noun-0]|TX|3431/2;[1503/2],[1584/2],[1665/2],[1702/2];1320/2;[1056/2],[1216/2];[504/2],[558/2],[599/2],[633/2],[678/2],[722/2],[829/2],[894/2]|Z01.542.727
00000000|MMI|161.43|Mongolia|C0026410|[geoa]|["MG"-tx-6-"MG"-noun-0,"MG"-tx-4-"MG"-noun-0,"MG"-tx-3-"MG"-noun-0]|TX|[1464/2],[1500/2],[1581/2],[1662/2],[1699/2];1053/2;[534/2],[555/2],[596/2],[630/2],[675/2],[891/2]|Z01.252.474.651
00000000|MMI|113.33|Oral|C0442027|[spco]|["PO"-tx-18-"PO"-noun-0,"PO"-tx-6-"PO"-noun-0,"PO"-tx-5-"PO"-noun-0,"PO"-tx-4-"PO"-noun-0,"PO"-tx-3-"PO"-noun-0]|TX|3431/2;[1503/2],[1584/2],[1665/2],[1702/2];1320/2;[1056/2],[1216/2];[504/2],[558/2],[599/2],[633/2],[678/2],[722/2],[829/2],[894/2]|
00000000|MMI|98.85|Patient Discharge|C0030685|[hlca]|["Discharge"-tx-35-"DISCHARGE"-noun-0,"Discharge"-tx-31-"DISCHARGE"-noun-0,"Discharged"-tx-29-"discharged"-verb-0,"Discharge"-tx-8-"DISCHARGE"-noun-0,"Patient Discharge"-tx-2-"DISCHARGE PATIENT"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|4416/9;4156/9;3940/10;2117/9;254/17;167/9|E02.204.125;E02.760.400.610;N02.421.192.125;N02.421.585.400.610;N04.590.233.727.210.125
00000000|MMI|74.60|Togo|C0040363|[geoa]|["TO"-tx-32-"to"-adv-0,"TO"-tx-30-"to"-adv-0,"TO"-tx-10-"to"-adv-0,"TO"-tx-8-"to"-adv-0]|TX|4259/2;4061/2;2963/2;[2008/2],[2877/2]|Z01.058.290.190.800
00000000|MMI|74.60|Tryptophanase|C0041260|[aapp,enzy]|["TO"-tx-32-"to"-adv-0,"TO"-tx-30-"to"-adv-0,"TO"-tx-10-"to"-adv-0,"TO"-tx-8-"to"-adv-0]|TX|4259/2;4061/2;2963/2;[2008/2],[2877/2]|D08.811.520.224.800
00000000|MMI|43.16|Magnesium Cation|C2346927|[elii,phsu]|["Mg++"-tx-6-"MG"-noun-0,"Mg++"-tx-4-"MG"-noun-0,"Mg++"-tx-3-"MG"-noun-0]|TX|[1464/2],[1500/2],[1581/2],[1662/2],[1699/2];1053/2;[534/2],[555/2],[596/2],[630/2],[675/2],[891/2]|
00000000|MMI|43.16|Milligram percent|C1960952|[qnco]|["mg %"-tx-6-"MG"-noun-0,"mg %"-tx-4-"MG"-noun-0,"mg %"-tx-3-"MG"-noun-0]|TX|[1464/2],[1500/2],[1581/2],[1662/2],[1699/2];1053/2;[534/2],[555/2],[596/2],[630/2],[675/2],[891/2]|
00000000|MMI|43.16|mg/dL|C0439269|[qnco]|["mg%"-tx-6-"MG"-noun-0,"mg%"-tx-4-"MG"-noun-0,"mg%"-tx-3-"MG"-noun-0]|TX|[1464/2],[1500/2],[1581/2],[1662/2],[1699/2];1053/2;[534/2],[555/2],[596/2],[630/2],[675/2],[891/2]|
00000000|MMI|40.07|Lesotho|C0023376|[geoa]|["LT"-tx-3-"lt"-noun-0]|TX|[698/2],[914/2],[923/2]|Z01.058.290.175.400
00000000|MMI|39.90|Dominican Republic|C0013014|[geoa]|["DR"-tx-31-"Dr"-noun-0,"DR"-tx-30-"Dr"-noun-0,"DR"-tx-7-"Dr"-noun-0]|TX|4232/2;4124/2;1984/2|Z01.107.084.900.300;Z01.639.880.300
00000000|MMI|39.57|Nigeria|C0028075|[geoa]|["NI"-tx-32-"ni"-noun-0,"NI"-tx-30-"ni"-noun-0,"NI"-tx-8-"ni"-noun-0]|TX|4271/2;4073/2;2020/2|Z01.058.290.190.565
00000000|MMI|39.30|Dilantin|C0699512|[orch,phsu]|["Dilantin"-tx-25-"dilantin"-noun-0,"Dilantin"-tx-4-"DILANTIN"-noun-0]|TX|3804/8;1026/8|D03.383.129.308.432.555.730
00000000|MMI|39.30|diagnosis aspect|C1704338|[qlco]|["diagnosis"-tx-8-"DIAGNOSIS"-noun-0]|TX|[2085/9],[2210/9]|x.x.x.x.x.x.x
00000000|MMI|32.14|Physicians|C0031831|[prog]|["DR"-tx-31-"Dr"-noun-0,"DR"-tx-30-"Dr"-noun-0,"DR"-tx-7-"Dr"-noun-0]|TX|4232/2;4124/2;1984/2|M01.526.485.810;N02.360.810
00000000|MMI|31.85|BaseLine dental cement|C0168634|[bodm]|["baseline"-tx-24-"baseline"-noun-0,"baseline"-tx-18-"baseline"-noun-0,"baseline"-tx-8-"baseline"-noun-0]|TX|3752/8;3416/8;2793/8|x.x.x.x
00000000|MMI|31.83|Isordil|C0590720|[orch,phsu]|["Isordil"-tx-15-"Isordil"-noun-0,"Isordil"-tx-3-"ISORDIL"-noun-0]|TX|3229/7;639/7|D02.033.800.813.480.500;D09.853.813.480.500
00000000|MMI|31.53|Lopressor|C0700776|[orch,phsu]|["Lopressor"-tx-22-"lopressor"-noun-0,"Lopressor"-tx-3-"LOPRESSOR"-noun-0]|TX|3645/9;852/9|D02.033.100.624.698.573;D02.033.755.624.698.573;D02.092.063.624.698.573
00000000|MMI|31.47|Lovenox|C0728963|[orch,phsu]|["Lovenox"-tx-27-"lovenox"-noun-0,"Lovenox"-tx-6-"LOVENOX"-noun-0]|TX|3863/7;1438/7|D09.698.373.400.300.200
00000000|MMI|31.42|Lasix|C0699992|[orch,phsu]|["Lasix"-tx-18-"lasix"-noun-0,"Lasix"-tx-3-"LASIX"-noun-0]|TX|3425/5;606/5|D02.065.884.725.300;D02.092.146.807.300;D02.886.590.700.725.300
00000000|MMI|29.02|Niacin|C0027996|[phsu,vita]|["NIACIN"-tx-6-"NIACIN"-noun-0,"NIACIN"-tx-5-"NIACIN"-noun-0]|TX|1789/6;1375/6|D03.066.515.475;D03.383.725.547.475
00000000|MMI|29.02|Vertigo|C0042571|[sosy]|["VERTIGO"-tx-8-"vertigo"-noun-0]|TX|[2356/7],[2366/7]|C09.218.568.900.883;C10.597.951;C23.888.592.958
00000000|MMI|26.42|skilled nursing facility|C0037265|[hcro,mnob]|["Skilled Nursing Facility"-tx-29-"skilled nursing facility"-noun-0,"Skilled Nursing Facility"-tx-3-"Skilled Nursing Facility"-noun-0]|TX|3954/24;428/24|N02.278.825.610.770
00000000|MMI|26.27|Food-Drug Interactions|C0242785|[dsyn]|["Interaction, Food-Drug"-tx-4-"Food/Drug Interaction"-noun-0,"Interaction, Food-Drug"-tx-3-"Food/Drug Interaction"-noun-0]|TX|1063/21;941/21|G07.690.773.968.511
00000000|MMI|24.70|Aspirin|C0004057|[orch,phsu]|["ASA"-tx-15-"ASA"-noun-0]|TX|3223/3|D02.455.426.559.389.657.410.595.176
00000000|MMI|24.64|Daily|C0332173|[tmco]|["QD"-tx-6-"QD"-noun-0,"QD"-tx-4-"QD"-noun-0,"QD"-tx-3-"QD"-noun-0]|TX|[1470/2],[1668/2],[1705/2];1219/2;[507/2],[636/2],[725/2],[832/2]|
00000000|MMI|23.87|Dementia|C0497327|[mobd]|["-- Dementia"-tx-8-"dementia"-noun-0]|TX|[2480/8],[2491/8]|C10.228.140.380;F03.615.400
00000000|MMI|23.87|Gastritis|C0017152|[dsyn]|["GASTRITIS"-tx-8-"gastritis"-noun-0]|TX|[2502/9],[2514/9]|C06.405.205.697;C06.405.748.398
00000000|MMI|23.33|Rough endoplasmic reticulum|C0230779|[celc]|["GER"-tx-8-"GER"-noun-0]|TX|2736/3|A11.284.430.214.190.875.248.300;A11.284.430.214.190.875.811.740.300
00000000|MMI|21.72|To|C1883351|[qlco]|["To"-tx-32-"to"-adv-0,"To"-tx-30-"to"-adv-0,"To"-tx-10-"to"-adv-0,"To"-tx-8-"to"-adv-0]|TX|4259/2;4061/2;2963/2;[2008/2],[2877/2]|
00000000|MMI|21.52|Atrial Fibrillation|C0004238|[dsyn]|["ATRIAL FIBRILLATION"-tx-19-"Atrial fibrillation"-noun-0,"ATRIAL FIBRILLATION"-tx-8-"atrial fibrillation"-noun-0]|TX|3452/19;2744/19|C14.280.067.198;C23.550.073.198
00000000|MMI|21.29|Rabbi|C0684010|[prog]|["R."-tx-8-"R"-noun-0,"R."-tx-4-"R"-noun-0]|TX|2629/1;1290/1|M01.526.799.500
00000000|MMI|21.24|Costa Rica|C0010182|[geoa]|["CRI"-tx-27-"CRI"-noun-0,"CRI"-tx-22-"CRI"-noun-0]|TX|3912/3;3661/3|Z01.107.169.238
00000000|MMI|21.16|Diurese|C0719972|[orch,phsu]|["Diurese"-tx-18-"diuresed"-verb-0]|TX|3381/8|D02.886.590.700.135.261.476.716;D02.886.655.500.261.476.716;D03.438.174.261.476.716
00000000|MMI|21.02|Pneumocystis jiroveci pneumonia|C1535939|[dsyn]|["PCP"-tx-31-"PCP"-noun-0,"PCP"-tx-30-"PCP"-noun-0]|TX|4228/3;4046/3|C01.703.534.700;C01.703.770.700;C08.381.472.700;C08.381.677.675;C08.730.435.700;C08.730.610.675
00000000|MMI|20.86|Hippocampus Proper|C3887642|[bpoc]|["CA"-tx-3-"CA"-adj-0]|TX|544/2|A08.186.211.464.405;A08.186.211.730.885.287.500.345
00000000|MMI|20.73|Simvastatin|C0074554|[orch,phsu]|["SIMVASTATIN"-tx-6-"SIMVASTATIN"-noun-0]|TX|1399/11|D02.455.426.559.847.638.400.900;D04.615.638.400.900
00000000|MMI|20.71|Zocor|C0678181|[orch,phsu]|["Zocor"-tx-5-"ZOCOR"-noun-0]|TX|1314/5|D02.455.426.559.847.638.400.900;D04.615.638.400.900
00000000|MMI|20.52|Anxiety Disorders|C0003469|[mobd]|["Anxiety"-tx-8-"anxiety"-noun-0,"Anxiety Disorder"-tx-8-"anxiety disorder"-noun-0]|TX|[2395/7],[2726/7];2376/16|F03.080
00000000|MMI|20.17|Override|C1547671|[acty]|["Override"-tx-7-"override"-verb-0,"Override"-tx-6-"Override"-verb-0,"Override"-tx-6-"overridden"-noun-0,"Override"-tx-6-"override"-verb-0,"Override"-tx-4-"Override"-verb-0]|TX|1845/8;1726/8;1714/10;1422/8;[1222/8],[1239/8]|
00000000|MMI|19.57|Cerebroside-Sulfatase|C0007804|[aapp,enzy]|["ASA"-tx-15-"ASA"-noun-0]|TX|3223/3|D08.811.277.352.827.070.250
00000000|MMI|19.57|Hydroxymethylglutaryl-CoA Reductase Inhibitors|C0360714|[orch,phsu]|["Statin"-tx-15-"statin"-noun-0]|TX|3239/6|D27.505.519.186.071.202.370;D27.505.519.389.370;D27.505.954.557.500.202.370
00000000|MMI|19.57|Phenytoin|C0031507|[orch,phsu]|["PHENYTOIN"-tx-4-"PHENYTOIN"-noun-0]|TX|1037/9|D03.383.129.308.432.555.730
00000000|MMI|19.57|Surgical aspects|C0038895|[ftcn]|["operations"-tx-8-"OPERATIONS"-noun-0]|TX|2558/10|x.x.x.x.x.x.x
00000000|MMI|19.57|Walking (activity)|C0080331|[dora]|["Walking"-tx-7-"Walking"-noun-0]|TX|1935/7|G11.427.590.530.568.900;G11.427.590.530.698.277.937;I03.350.937;I03.450.642.845.940
00000000|MMI|18.73|Anxiety|C0003467|[mobd]|["-- Anxiety"-tx-8-"anxiety"-noun-0]|TX|[2395/7],[2726/7]|F01.470.132
00000000|MMI|18.19|therapeutic aspects|C0039798|[ftcn]|["treatment"-tx-8-"Treatment"-noun-0]|TX|2272/9|x.x.x.x.x.x.x
00000000|MMI|17.01|Atenolol|C0004147|[orch,phsu]|["ATENOLOL"-tx-22-"Atenolol"-noun-0]|TX|3607/8|D02.033.100.624.698.070;D02.033.755.624.698.070;D02.092.063.624.698.070
00000000|MMI|17.01|Docusate Sodium|C0243237|[orch,phsu]|["DOCUSATE SODIUM"-tx-3-"DOCUSATE SODIUM"-noun-0]|TX|574/15|D02.241.081.337.759.249
00000000|MMI|17.01|Enoxaparin|C0206460|[orch,phsu]|["Enoxaparine"-tx-6-"ENOXAPARIN"-noun-0]|TX|1448/10|D09.698.373.400.300.200
00000000|MMI|17.01|Esomeprazole|C0937846|[orch,phsu]|["ESOMEPRAZOLE"-tx-6-"ESOMEPRAZOLE"-noun-0]|TX|1644/12|D02.886.640.074.500.500;D03.383.725.024.500.500;D03.438.103.034.500.500
00000000|MMI|17.01|Furosemide|C0016860|[orch,phsu]|["FUROSEMIDE"-tx-3-"FUROSEMIDE"-noun-0]|TX|614/10|D02.065.884.725.300;D02.092.146.807.300;D02.886.590.700.725.300
00000000|MMI|17.01|Isosorbide Dinitrate|C0022252|[orch,phsu]|["ISOSORBIDE DINITRATE"-tx-3-"ISOSORBIDE DINITRATE"-noun-0]|TX|649/20|D02.033.800.813.480.500;D09.853.813.480.500
00000000|MMI|17.01|Magnesium Hydroxide|C0024476|[inch,phsu]|["MAGNESIUM HYDROXIDE"-tx-3-"MAGNESIUM HYDROXIDE"-noun-0]|TX|792/19|D01.045.250.575;D01.248.497.158.459.388;D01.524.485
00000000|MMI|17.01|Metoprolol Tartrate|C0700548|[orch,phsu]|["METOPROLOL TARTRATE"-tx-3-"METOPROLOL TARTRATE"-noun-0]|TX|864/19|D02.033.100.624.698.573;D02.033.755.624.698.573;D02.092.063.624.698.573
00000000|MMI|16.45|Disease|C0012634|[dsyn]|["condition"-tx-31-"CONDITION"-noun-0,"condition"-tx-8-"Conditions"-noun-0]|TX|4166/9;2220/10|C23.550.288
00000000|MMI|16.45|Hypertensive disease|C0020538|[dsyn]|["HTN"-tx-8-"HTN"-noun-0,"HYPERTENSION"-tx-8-"hypertension"-noun-0]|TX|2287/3;2293/12|C14.907.489
00000000|MMI|16.25|Failure to Thrive|C0015544|[dsyn]|["FAILURE TO THRIVE"-tx-8-"failure to thrive"-noun-0,"FAILURE TO THRIVE"-tx-1-"failure to thrive"-noun-0]|TX|2186/17;64/17|C23.888.338
00000000|MMI|15.79|Nexium|C0939400|[orch,phsu]|["Nexium"-tx-6-"NEXIUM"-noun-0]|TX|1635/6|D02.886.640.074.500.500;D03.383.725.024.500.500;D03.438.103.034.500.500
00000000|MMI|15.75|Risk|C0035647|[idcn]|["Risk"-tx-16-"risk"-noun-0]|TX|3271/4|E05.318.740.600.800;G17.680.750;N05.715.360.750.625.700;N06.850.520.830.600.800
00000000|MMI|15.73|Colace|C0282139|[orch,phsu]|["Colace"-tx-3-"COLACE"-noun-0]|TX|565/6|D02.241.081.337.759.249
00000000|MMI|15.72|Meal (occasion for eating)|C1998602|[dora]|["Meals"-tx-3-"meals"-noun-0]|TX|998/5|F01.145.407.432.500;F01.145.466.349.500;G07.203.300.590;G07.203.650.353.432.500;J02.500.590
00000000|MMI|15.68|District of Columbia|C0012764|[geoa]|["D.C."-tx-2-"D/C"-noun-0]|TX|331/3|Z01.107.567.875.500.210;Z01.433.429
00000000|MMI|15.65|Gastroesophageal reflux disease|C0017168|[dsyn]|["GER"-tx-8-"GER"-noun-0]|TX|2736/3|C06.405.117.119.500.484
00000000|MMI|15.28|Hospital admission|C0184666|[hlca]|["admitted"-tx-11-"Admitted"-verb-0,"admissions"-tx-9-"admissions"-noun-0,"Admission"-tx-8-"Admission"-noun-0,"Admit"-tx-8-"ADMIT"-verb-0,"admitted"-tx-8-"admitted"-verb-0]|TX|3018/8;2922/10;2174/9;2079/5;2804/8|
00000000|MMI|14.45|Barbados|C0004739|[geoa]|["BB"-tx-15-"BB"-noun-0]|TX|3248/2|Z01.107.084.900.140;Z01.639.880.140
00000000|MMI|14.45|Coronary Arteriosclerosis|C0010054|[dsyn]|["coronary artery disease"-tx-8-"coronary artery disease"-noun-0]|TX|2532/23|C14.280.647.250.260;C14.907.137.126.339;C14.907.585.250.260
00000000|MMI|14.45|Coronary Artery Disease|C1956346|[dsyn]|["CORONARY ARTERY DISEASE"-tx-8-"coronary artery disease"-noun-0]|TX|2532/23|C14.280.647.250.260;C14.907.137.126.339;C14.907.585.250.260
00000000|MMI|13.26|Fat-Restricted Diet|C0242970|[topp]|["Low fat diet, NOS"-tx-7-"Low fat DIET"-noun-0]|TX|1882/3,1901/8|E02.642.249.260;G07.203.650.240.260
00000000|MMI|13.18|Calcium Carbonate|C0006681|[inch,phsu]|["CALCIUM CARBONATE"-tx-3-"CALCIUM CARBONATE"-noun-0]|TX|510/17|D01.146.275;D01.200.275.150.150;D01.578.200
00000000|MMI|13.17|Lipitor|C0593906|[orch,phsu]|["Lipitor"-tx-6-"LIPITOR"-noun-0]|TX|1671/7|D03.383.129.578.075;D10.251.450.200
00000000|MMI|13.14|Treatment Protocols|C0040808|[topp]|["Regimen"-tx-15-"regimen"-noun-0]|TX|3214/7|E02.183;N05.715.360.775.225
00000000|MMI|13.07|Chest Pain|C0008031|[sosy]|["CHEST PAIN"-tx-8-"chest pain"-noun-1]|TX|2096/10|C10.597.617.192;C23.888.592.612.233
00000000|MMI|13.07|Atorvastatin calcium|C0286650|[orch,phsu]|["ATORVASTATIN CALCIUM"-tx-7-"ATORVASTATIN CALCIUM"-noun-0]|TX|1813/20|D03.383.129.578.075;D10.251.450.200
00000000|MMI|13.05|Saint Kitts and Nevis|C0282380|[geoa]|["SC"-tx-6-"SC"-noun-0]|TX|1467/2|Z01.107.084.900.787;Z01.639.880.787
00000000|MMI|13.03|Electrocardiogram|C0013798|[fndg]|["EKG"-tx-14-"EKG"-noun-1]|TX|3178/3|E01.370.370.380.240;E01.370.405.240
00000000|MMI|13.03|Electrocardiography|C1623258|[diap]|["EKG"-tx-14-"EKG"-noun-0]|TX|3178/3|E01.370.370.380.240;E01.370.405.240
00000000|MMI|13.02|Pain|C0030193|[sosy]|["PAIN"-tx-3-"Pain"-noun-0]|TX|781/4|C10.597.617;C23.888.592.612;F02.830.816.444;G11.561.600.810.444
00000000|MMI|12.75|Hold (action)|C1948035|[acty]|["Hold"-tx-4-"hold"-verb-0,"Hold"-tx-3-"HOLD"-verb-0]|TX|1131/4;[685/4],[901/4]|
00000000|MMI|12.75|Hold - dosing instruction fragment|C1553387|[idcn]|["Hold"-tx-4-"hold"-verb-0,"Hold"-tx-3-"HOLD"-verb-0]|TX|1131/4;[685/4],[901/4]|
00000000|MMI|12.75|Pharmacogenomics Trial Characteristics Domain|C3714755|[inpr]|["PT"-tx-32-"Pt"-noun-0,"PT"-tx-30-"Pt"-noun-0,"PT"-tx-29-"Pt"-noun-0]|TX|4250/2;4021/2;3929/2|
00000000|MMI|12.75|Physical therapy (field)|C0699718|[bmod]|["PT"-tx-32-"Pt"-noun-0,"PT"-tx-30-"Pt"-noun-0,"PT"-tx-29-"Pt"-noun-0]|TX|4250/2;4021/2;3929/2|
00000000|MMI|12.75|hold - Data Operation|C3853841|[ftcn]|["hold"-tx-4-"hold"-verb-0,"hold"-tx-3-"HOLD"-verb-0]|TX|1131/4;[685/4],[901/4]|
00000000|MMI|12.40|Order (action)|C1705178|[acty]|["Order"-tx-35-"ORDERS"-verb-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-2-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|4426/6;1304/5;335/5;177/6|
00000000|MMI|12.40|Order (arrangement)|C1705176|[qlco]|["Order"-tx-35-"ORDERS"-verb-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-2-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|4426/6;1304/5;335/5;177/6|
00000000|MMI|12.40|Order (document)|C1705175|[inpr]|["Order"-tx-35-"ORDERS"-verb-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-2-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|4426/6;1304/5;335/5;177/6|
00000000|MMI|12.40|Order (taxonomic)|C1705177|[clas]|["Order"-tx-35-"ORDERS"-verb-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-2-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|4426/6;1304/5;335/5;177/6|
00000000|MMI|12.40|Permutation|C1882348|[qlco]|["Order"-tx-35-"ORDERS"-verb-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-2-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|4426/6;1304/5;335/5;177/6|
00000000|MMI|12.40|Sequence of Planned Assessment Schedule|C3889825|[inpr]|["ORDER"-tx-35-"ORDERS"-verb-0,"ORDER"-tx-5-"order"-noun-0,"ORDER"-tx-2-"ORDER"-noun-0,"ORDER"-tx-1-"ORDERS"-verb-0]|TX|4426/6;1304/5;335/5;177/6|
00000000|MMI|12.10|Negation|C1518422|[ftcn]|["Not"-tx-27-"not"-adv-0,"Not"-tx-20-"Not"-adv-0,"Not"-tx-10-"not"-adv-0,"Not"-tx-8-"NOT"-adv-0]|TX|3882/3;3507/3;2959/3;2620/3|
00000000|MMI|11.89|Cataract Extraction|C0007389|[topp]|["cataract surgery"-tx-8-"cataract surgery"-noun-0]|TX|2446/16|E04.540.825.249
00000000|MMI|11.89|Coronary heart disease|C0010068|[dsyn]|["Coronary (artery) disease"-tx-8-"coronary artery disease"-noun-0]|TX|2532/23|C14.280.647.250;C14.907.585.250
00000000|MMI|11.89|Diet|C0012155|[food]|["Diet"-tx-7-"DIET"-noun-0]|TX|1868/4|G07.203.650.240
00000000|MMI|11.89|Mirtazapine|C0049506|[orch,phsu]|["MIRTAZAPINE"-tx-6-"MIRTAZAPINE"-noun-0]|TX|1483/11|x.x.x.x
00000000|MMI|11.89|Rehabilitation therapy|C0034991|[topp]|["Rehab"-tx-27-"rehab"-noun-0]|TX|3874/5|E02.831;H02.403.680.600;N02.421.784
00000000|MMI|11.89|olanzapine|C0171023|[orch,phsu]|["OLANZAPINE"-tx-6-"OLANZAPINE"-noun-0]|TX|1564/10|x.x.x.x
00000000|MMI|11.85|Body Fluid Discharge|C0012621|[bdsu]|["Discharge"-tx-35-"DISCHARGE"-noun-0,"Discharge"-tx-31-"DISCHARGE"-noun-0,"Discharge"-tx-8-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|4416/9;4156/9;2117/9;167/9|
00000000|MMI|11.85|Discharge, body substance|C2926602|[bdsu]|["Discharge"-tx-35-"DISCHARGE"-noun-0,"Discharge"-tx-31-"DISCHARGE"-noun-0,"Discharge"-tx-8-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|4416/9;4156/9;2117/9;167/9|
00000000|MMI|11.75|Three times daily|C0556984|[tmco]|["TID"-tx-22-"TID"-noun-0,"TID"-tx-3-"TID"-noun-0]|TX|3631/3;[561/3],[681/3],[897/3]|
00000000|MMI|11.75|three times a day at institution-specified times|C1610169|[tmco]|["TID"-tx-22-"TID"-noun-0,"TID"-tx-3-"TID"-noun-0]|TX|3631/3;[561/3],[681/3],[897/3]|
00000000|MMI|11.01|Educational process of instructing|C0039401|[edac]|["Instruction"-tx-4-"Instruction"-noun-0,"Instruction"-tx-3-"Instruction"-noun-0]|TX|1085/11;963/11|I02.903
00000000|MMI|10.83|Heart|C0018787|[bpoc]|["Cardiac"-tx-15-"cardiac"-adj-0,"coronary"-tx-10-"coronary"-adj-0]|TX|3206/7;2993/8|A07.541
00000000|MMI|10.79|Bradycardia|C0428977|[patf]|["Bradycardias"-tx-21-"bradycardic"-adj-0]|TX|3547/11|C14.280.067.319;C23.550.073.300
00000000|MMI|10.67|Diuresis|C0012797|[ortf]|["Diuresis"-tx-11-"diuresis"-noun-0]|TX|3045/8|G08.852.796.241
00000000|MMI|10.62|Infantile Neuroaxonal Dystrophy|C0270724|[dsyn]|["PLAN"-tx-31-"PLAN"-noun-0]|TX|4190/4|C10.228.140.744
00000000|MMI|10.58|Stomach|C0038351|[bpoc]|["STOMACH"-tx-3-"stomach"-noun-0]|TX|1016/7|A03.556.875.875
00000000|MMI|10.57|4-azido-7-phenylpyrazolo-(1,5a)-1,3,5-triazine|C0245203|[bacs,orch]|["APPT"-tx-31-"appt"-noun-0]|TX|4218/4|x.x.x.x
00000000|MMI|10.57|Single-Stranded Conformational Polymorphism|C0243031|[lbtr]|["SSCP"-tx-8-"SSCP"-noun-0]|TX|2835/4|G05.365.795.600
00000000|MMI|10.56|Set (Psychology)|C0036849|[menp]|["Set"-tx-13-"sets"-noun-1]|TX|3129/4|F02.463.425.838
00000000|MMI|10.55|Dilatation and Curettage|C0012358|[topp]|["D & C"-tx-2-"D/C"-noun-0]|TX|331/3|E04.157.310;E04.950.300.299
00000000|MMI|10.53|Awareness|C0004448|[menp]|["Aware"-tx-6-"aware"-adj-0]|TX|1432/5|F02.463.188.150
00000000|MMI|10.50|Sodium|C0037473|[bacs,elii]|["SODIUM"-tx-7-"Sodium"-noun-0]|TX|1918/6|D01.268.549.750;D01.268.557.650;D01.552.528.850;D01.552.547.725;x.x.x.x
00000000|MMI|10.49|Honduras|C0019905|[geoa]|["HO"-tx-3-"ho"-noun-0]|TX|938/2|Z01.107.169.534
00000000|MMI|10.49|Constipation|C0009806|[sosy]|["CONSTIPATION"-tx-3-"Constipation"-noun-0]|TX|839/12|C23.888.821.150
00000000|MMI|10.47|Panama|C0030266|[geoa]|["PM"-tx-2-"PM"-adj-0]|TX|292/2|Z01.107.169.772
00000000|MMI|10.47|Family|C0015576|[famg]|["Family"-tx-29-"family"-noun-0]|TX|4012/6|F01.829.263;I01.880.853.150
00000000|MMI|9.40|Readiness|C1318963|[fndg]|["Readiness"-tx-32-"ready"-adj-0,"Readiness"-tx-30-"ready"-adj-0,"Readiness"-tx-8-"ready"-adj-0]|TX|4253/5;4055/5;2002/5|
00000000|MMI|9.33|Cataract|C0086543|[acab]|["CATARACT"-tx-8-"cataract"-noun-0]|TX|2469/8|C11.510.245
00000000|MMI|9.33|Complication Aspects|C1171258|[patf]|["complications"-tx-8-"Complications"-noun-0]|TX|2246/13|x.x.x
00000000|MMI|9.33|Diet therapy|C0012159|[hlca]|["Diet"-tx-7-"DIET"-noun-0]|TX|1868/4|E02.642.249
00000000|MMI|9.33|Ischemia|C0022116|[patf]|["Ischaemia, NOS"-tx-13-"Ischemia"-noun-0]|TX|3104/8|C23.550.513
00000000|MMI|9.33|Methods aspects|C0025664|[inpr]|["procedures"-tx-8-"PROCEDURES"-noun-0]|TX|2573/10|x.x.x
00000000|MMI|9.33|Patient Monitoring|C0030695|[hlca]|["monitor"-tx-7-"monitor"-verb-0]|TX|1860/7|E01.370.520
00000000|MMI|9.04|4+ Answer to question|C3838679|[fndg]|["4+"-tx-35-"4"-fraction-0,"4+"-tx-28-"4"-integer-0,"4+"-tx-2-"4"-fraction-0]|TX|4390/1;3919/1;276/1|
00000000|MMI|9.02|Lymphotoxin-Alpha, human|C3887647|[aapp,imft]|["LT"-tx-3-"lt"-noun-0]|TX|[698/2],[914/2],[923/2]|
00000000|MMI|9.02|Structure of left thigh|C0230426|[bpoc]|["LT"-tx-3-"lt"-noun-0]|TX|[698/2],[914/2],[923/2]|
00000000|MMI|8.91|Medical|C0205476|[ftcn]|["Medical"-tx-32-"Medical"-adj-0,"Medical"-tx-30-"Medical"-adj-0,"Medical"-tx-8-"Medical"-adj-0]|TX|4301/7;4103/7;2050/7|
00000000|MMI|8.91|Medical service|C0199168|[hlca]|["Medical"-tx-32-"Medical"-adj-0,"Medical"-tx-30-"Medical"-adj-0,"Medical"-tx-8-"Medical"-adj-0]|TX|4301/7;4103/7;2050/7|
00000000|MMI|8.90|Admission activity|C0809949|[hlca]|["Admitted"-tx-11-"Admitted"-verb-0,"Admission"-tx-8-"Admission"-noun-0,"Admitted"-tx-8-"admitted"-verb-0]|TX|3018/8;2174/9;2804/8|
00000000|MMI|8.85|Delayed Release Dosage Form|C1707664|[bodm]|["DR"-tx-31-"Dr"-noun-0,"DR"-tx-30-"Dr"-noun-0,"DR"-tx-7-"Dr"-noun-0]|TX|4232/2;4124/2;1984/2|
00000000|MMI|8.85|Device to Subject Relationship Domain|C3540849|[inpr]|["DR"-tx-31-"Dr"-noun-0,"DR"-tx-30-"Dr"-noun-0,"DR"-tx-7-"Dr"-noun-0]|TX|4232/2;4124/2;1984/2|
00000000|MMI|8.85|Doctor - Title|C2348314|[cnce]|["Dr."-tx-31-"Dr"-noun-0,"Dr."-tx-30-"Dr"-noun-0,"Dr."-tx-7-"Dr"-noun-0]|TX|4232/2;4124/2;1984/2|
00000000|MMI|8.69|Clinical Study Follow-up|C3274571|[hlca]|["FOLLOW-UP"-tx-31-"follow-up"-adj-0,"FOLLOW-UP"-tx-30-"follow up"-adj-0,"FOLLOW-UP"-tx-7-"FOLLOW UP"-adj-0]|TX|4208/9;4031/9;1956/9|
00000000|MMI|8.69|Follow-Up Report|C1704685|[inpr]|["Follow-Up"-tx-31-"follow-up"-adj-0,"Follow-Up"-tx-30-"follow up"-adj-0,"Follow-Up"-tx-7-"FOLLOW UP"-adj-0]|TX|4208/9;4031/9;1956/9|
00000000|MMI|8.69|Follow-up status|C0589120|[fndg]|["Follow-up"-tx-31-"follow-up"-adj-0,"Follow-up"-tx-30-"follow up"-adj-0,"Follow-up"-tx-7-"FOLLOW UP"-adj-0]|TX|4208/9;4031/9;1956/9|
00000000|MMI|8.69|follow-up|C1522577|[hlca]|["Follow Up"-tx-31-"follow-up"-adj-0,"Follow Up"-tx-30-"follow up"-adj-0,"Follow Up"-tx-7-"FOLLOW UP"-adj-0]|TX|4208/9;4031/9;1956/9|
00000000|MMI|8.66|Home environment|C0442519|[cnce]|["HOME"-tx-25-"home"-noun-0,"HOME"-tx-8-"home"-adj-0,"house"-tx-7-"House"-noun-0]|TX|3773/4;2888/4;1874/5|
00000000|MMI|8.57|Baseline|C1442488|[qnco]|["Baseline"-tx-24-"baseline"-noun-0,"Baseline"-tx-18-"baseline"-noun-0,"Baseline"-tx-8-"baseline"-noun-0]|TX|3752/8;3416/8;2793/8|
00000000|MMI|8.51|Dietary Nickel|C2348274|[elii]|["Ni"-tx-32-"ni"-noun-0,"Ni"-tx-30-"ni"-noun-0,"Ni"-tx-8-"ni"-noun-0]|TX|4271/2;4073/2;2020/2|
00000000|MMI|8.51|NI+|C3869926|[fndg]|["NI+"-tx-32-"ni"-noun-0,"NI+"-tx-30-"ni"-noun-0,"NI+"-tx-8-"ni"-noun-0]|TX|4271/2;4073/2;2020/2|
00000000|MMI|8.51|NI-|C3869927|[fndg]|["NI-"-tx-32-"ni"-noun-0,"NI-"-tx-30-"ni"-noun-0,"NI-"-tx-8-"ni"-noun-0]|TX|4271/2;4073/2;2020/2|
00000000|MMI|8.51|Pulsatility index, arterial velocity waveform|C0429863|[clna]|["PI"-tx-32-"Pi"-noun-0,"PI"-tx-30-"Pi"-noun-0,"PI"-tx-8-"Pi"-noun-0]|TX|4268/2;4070/2;2017/2|
00000000|MMI|8.51|SERPINA1 wt Allele|C3537219|[gngm]|["PI"-tx-32-"Pi"-noun-0,"PI"-tx-30-"Pi"-noun-0,"PI"-tx-8-"Pi"-noun-0]|TX|4268/2;4070/2;2017/2|
00000000|MMI|8.51|STANDARDS Pain Intensity Questionnaire|C3539772|[inpr]|["PI"-tx-32-"Pi"-noun-0,"PI"-tx-30-"Pi"-noun-0,"PI"-tx-8-"Pi"-noun-0]|TX|4268/2;4070/2;2017/2|
00000000|MMI|8.45|Anxiety Scale (BASC-2)|C4050613|[inpr]|["Anxiety"-tx-8-"anxiety"-noun-0]|TX|[2395/7],[2726/7]|
00000000|MMI|8.45|Approximate|C0332232|[qlco]|["Approximate"-tx-6-"approximate"-adj-0]|TX|[1537/11],[1618/11]|
00000000|MMI|8.45|Diagnosis|C0011900|[fndg]|["DIAGNOSIS"-tx-8-"DIAGNOSIS"-noun-0,"DIAGNOSIS"-tx-8-"DIAGNOSIS"-noun-1]|TX|[2085/9],[2210/9];[2085/9],[2210/9]|E01
00000000|MMI|8.45|Diagnosis Study|C1704656|[resa]|["DIAGNOSIS"-tx-8-"DIAGNOSIS"-noun-0]|TX|[2085/9],[2210/9]|
00000000|MMI|8.45|Doctor of Medicine|C1512018|[inpr]|["M.D."-tx-34-"M.D"-noun-0,"M.D."-tx-2-"M.D"-noun-0]|TX|4376/3;410/3|
00000000|MMI|8.45|Presenile dementia|C0011265|[mobd]|["dementia"-tx-8-"dementia"-noun-0]|TX|[2480/8],[2491/8]|
00000000|MMI|8.45|Requirement|C1514873|[ftcn]|["Required"-tx-6-"Required"-verb-0]|TX|[1526/8],[1607/8]|
00000000|MMI|8.45|VIT gene|C1421454|[gngm]|["VIT"-tx-6-"VIT"-noun-0,"VIT"-tx-5-"VIT"-noun-0]|TX|1798/3;1384/3|
00000000|MMI|8.45|Vertigo <invertebrate>|C1069915|[euka]|["Vertigo"-tx-8-"vertigo"-noun-0]|TX|[2356/7],[2366/7]|
00000000|MMI|8.45|Vitamin B3 Assay|C1142562|[lbpr]|["Niacin"-tx-6-"NIACIN"-noun-0,"Niacin"-tx-5-"NIACIN"-noun-0]|TX|1789/6;1375/6|
00000000|MMI|8.45|orders - HL7PublishingDomain|C3244315|[inpr]|["orders"-tx-35-"ORDERS"-verb-0,"orders"-tx-1-"ORDERS"-verb-0]|TX|4426/6;177/6|
00000000|MMI|8.45|Once a day, at bedtime|C1275563|[tmco]|["qHS"-tx-6-"QHS"-noun-0,"qHS"-tx-4-"QHS"-noun-0]|TX|[1506/3],[1587/3];1059/3|
00000000|MMI|8.07|Appointments|C0003629|[idcn]|["Appointment"-tx-7-"APPOINTMENT"-noun-0]|TX|1966/11|N04.452.095
00000000|MMI|8.01|Back|C0004600|[blor]|["BACK"-tx-18-"back"-adj-0]|TX|3408/4|A01.923.176
00000000|MMI|7.94|Tablet Dosage Form|C0039225|[bodm]|["TAB"-tx-4-"TAB"-noun-0]|TX|1212/3|D26.255.830
00000000|MMI|6.77|Coping Behavior|C0009967|[inbe]|["cope"-tx-8-"cope"-verb-0]|TX|2880/4|F01.058
00000000|MMI|6.77|Infection|C3714514|[patf]|["Infections"-tx-8-"Infections"-noun-0]|TX|2233/10|C01.539
00000000|MMI|6.24|Zyprexa|C0527258|[orch,phsu]|["ZyPREXA"-tx-25-"zyprexa"-noun-0,"ZyPREXA"-tx-6-"ZYPREXA"-noun-0]|TX|3794/7;1554/7|
00000000|MMI|6.17|Condition|C0348080|[qlco]|["Condition"-tx-31-"CONDITION"-noun-0,"Condition"-tx-8-"Conditions"-noun-0]|TX|4166/9;2220/10|
00000000|MMI|6.17|Condition:Find:Pt:^Patient:Nom|C3864998|[clna]|["Condition"-tx-31-"CONDITION"-noun-0,"Condition"-tx-8-"Conditions"-noun-0]|TX|4166/9;2220/10|
00000000|MMI|6.17|Logical Condition|C1705253|[cnce]|["Condition"-tx-31-"CONDITION"-noun-0,"Condition"-tx-8-"Conditions"-noun-0]|TX|4166/9;2220/10|
00000000|MMI|6.12|Remeron|C0525726|[orch,phsu]|["Remeron"-tx-25-"remeron"-noun-0,"Remeron"-tx-6-"REMERON"-noun-0]|TX|3784/7;1473/7|
00000000|MMI|6.10|Atrial Fibrillation Adverse Event|C1963067|[fndg]|["Atrial fibrillation"-tx-19-"Atrial fibrillation"-noun-0,"Atrial fibrillation"-tx-8-"atrial fibrillation"-noun-0]|TX|3452/19;2744/19|
00000000|MMI|6.10|Atrial Fibrillation by ECG Finding|C0344434|[lbtr]|["Atrial Fibrillation"-tx-19-"Atrial fibrillation"-noun-0,"Atrial Fibrillation"-tx-8-"atrial fibrillation"-noun-0]|TX|3452/19;2744/19|
00000000|MMI|6.03|Changed status|C0443172|[qnco]|["Changed"-tx-22-"changed"-verb-0,"Changed"-tx-18-"changed"-verb-0]|TX|3620/7;3400/7|
00000000|MMI|6.03|Changing|C0392747|[ftcn]|["Changed"-tx-22-"changed"-verb-0,"Changed"-tx-18-"changed"-verb-0]|TX|3620/7;3400/7|
00000000|MMI|5.97|Failure to thrive in infant|C3887638|[dsyn]|["Failure to Thrive"-tx-8-"failure to thrive"-noun-0,"Failure to Thrive"-tx-1-"failure to thrive"-noun-0]|TX|2186/17;64/17|
00000000|MMI|5.97|Pediatric failure to thrive|C2315100|[dsyn]|["Failure to Thrive"-tx-8-"failure to thrive"-noun-0,"Failure to Thrive"-tx-1-"failure to thrive"-noun-0]|TX|2186/17;64/17|
00000000|MMI|5.93|Continuous|C0549178|[idcn]|["Continue"-tx-27-"continue"-verb-0,"Continued"-tx-25-"Continued"-adj-0]|TX|3831/8;3763/9|
00000000|MMI|5.93|Therapeutic procedure|C0087111|[topp]|["Treatment"-tx-8-"Treatment"-noun-0,"Therapeutic"-tx-4-"THERAPEUTIC"-adj-0]|TX|2272/9;1168/11|E02
00000000|MMI|5.92|Interaction|C1704675|[ftcn]|["Interaction"-tx-6-"INTERACTION"-noun-0,"Interaction"-tx-5-"INTERACTION"-noun-0]|TX|1776/11;1362/11|
00000000|MMI|5.91|+2|C0740116|[qnco]|["+2"-tx-23-"2"-integer-0,"+2"-tx-7-"2"-integer-0]|TX|3730/1;1911/1|
00000000|MMI|5.91|1+|C3816745|[fndg]|["1+"-tx-12-"1"-integer-0,"1+"-tx-4-"1"-integer-0]|TX|3096/1;1210/1|
00000000|MMI|5.91|1+ Score|C2827734|[qnco]|["1+"-tx-12-"1"-integer-0,"1+"-tx-4-"1"-integer-0]|TX|3096/1;1210/1|
00000000|MMI|5.91|1+ Score, WHO|C2981698|[clas]|["1+"-tx-12-"1"-integer-0,"1+"-tx-4-"1"-integer-0]|TX|3096/1;1210/1|
00000000|MMI|5.91|2+|C3833492|[fndg]|["2+"-tx-23-"2"-integer-0,"2+"-tx-7-"2"-integer-0]|TX|3730/1;1911/1|
00000000|MMI|5.91|2+ Score|C2827735|[qnco]|["2+"-tx-23-"2"-integer-0,"2+"-tx-7-"2"-integer-0]|TX|3730/1;1911/1|
00000000|MMI|5.91|2+ Score, WHO|C2981700|[clas]|["2+"-tx-23-"2"-integer-0,"2+"-tx-7-"2"-integer-0]|TX|3730/1;1911/1|
00000000|MMI|5.89|Course|C0750729|[tmco]|["Course"-tx-21-"course"-noun-0,"Course"-tx-12-"Course"-noun-0]|TX|3598/6;3088/6|
00000000|MMI|5.88|Summary (document)|C1706244|[inpr]|["Summary"-tx-33-"summary"-noun-0,"Summary"-tx-2-"SUMMARY"-noun-0]|TX|4336/7;360/7|
00000000|MMI|5.88|summary - ActRelationshipSubset|C1552616|[inpr]|["summary"-tx-33-"summary"-noun-0,"summary"-tx-2-"SUMMARY"-noun-0]|TX|4336/7;360/7|
00000000|MMI|5.87|Instruction [Publication Type]|C0302828|[inpr]|["Instruction"-tx-4-"Instruction"-noun-0,"Instruction"-tx-3-"Instruction"-noun-0]|TX|1085/11;963/11|
00000000|MMI|5.87|Instructions|C1442085|[idcn]|["instruction"-tx-4-"Instruction"-noun-0,"instruction"-tx-3-"Instruction"-noun-0]|TX|1085/11;963/11|
00000000|MMI|5.87|R prime|C2603358|[clna]|["R'"-tx-8-"R"-noun-0,"R'"-tx-4-"R"-noun-0]|TX|2629/1;1290/1|
00000000|MMI|5.87|Right|C0205090|[spco]|["R-"-tx-8-"R"-noun-0,"R-"-tx-4-"R"-noun-0]|TX|2629/1;1290/1|
00000000|MMI|5.85|demented|C0860630|[mobd]|["demented"-tx-24-"Demented"-noun-0,"demented"-tx-8-"demented"-verb-0]|TX|3740/8;2781/8|
00000000|MMI|5.84|CALD1 wt Allele|C3813548|[gngm]|["CAD"-tx-8-"CAD"-adj-0,"CAD"-tx-8-"cad"-noun-0]|TX|2697/3;2526/3|
00000000|MMI|5.83|Indication of (contextual qualifier)|C0392360|[idcn]|["Reason"-tx-7-"Reason"-noun-0,"Reason"-tx-6-"Reason"-noun-0]|TX|1834/6;1411/6|
00000000|MMI|5.81|Complete Response with Incomplete Bone Marrow Recovery|C3538993|[fndg]|["CRi"-tx-27-"CRI"-noun-1,"CRi"-tx-22-"CRI"-noun-0]|TX|3912/3;3661/3|
00000000|MMI|5.81|Cranial Rhythmic Impulse|C1704519|[phsf]|["CRI"-tx-27-"CRI"-noun-1,"CRI"-tx-22-"CRI"-noun-0]|TX|3912/3;3661/3|
00000000|MMI|5.81|RNH1 gene|C1826843|[gngm]|["CRI"-tx-27-"CRI"-noun-0,"CRI"-tx-22-"CRI"-noun-0]|TX|3912/3;3661/3|
00000000|MMI|5.80|Additional|C1524062|[ftcn]|["Added"-tx-6-"added"-verb-0,"Added"-tx-4-"added"-verb-0]|TX|1735/5;1248/5|
00000000|MMI|5.79|Dose number|C1115464|[qnco]|["Dose number"-tx-6-"Number Doses"-noun-0]|TX|[1510/6,1520/5],[1591/6,1601/5]|
00000000|MMI|5.79|Dose number:Number:Point in time:^Patient:Quantitative|C1114758|[clna]|["Dose number"-tx-6-"Number Doses"-noun-0]|TX|[1510/6,1520/5],[1591/6,1601/5]|
00000000|MMI|5.79|Emotions|C0013987|[menp]|["feel"-tx-10-"Felt"-verb-0]|TX|2954/4|F01.470
00000000|MMI|5.76|((5,6-dichloro-2,3,9,9a-tetrahydro-3-oxo-9a-propyl-1H-fluoren-7-yl)oxy)acetic acid|C0378071|[orch,phsu]|["b-3"-tx-7-"B-3"-adj-0,"b-3"-tx-6-"B-3"-adj-0]|TX|1803/3;1389/3|
00000000|MMI|5.71|10%|C3842590|[fndg]|["10%"-tx-8-"10"-fraction-0,"10%"-tx-1-"10"-fraction-0]|TX|2825/2;108/2|
00000000|MMI|5.69|Discontinued|C1444662|[fndg]|["D/C"-tx-2-"D/C"-noun-1,"DIS"-tx-1-"DIS"-noun-0]|TX|331/3;86/3|
00000000|MMI|5.69|Mild (qualifier value)|C2945599|[qlco]|["Mildly"-tx-17-"Mildly"-adv-0,"MILD"-tx-8-"mild"-adj-0]|TX|3330/6;2842/4|
00000000|MMI|5.67|Serious|C0205404|[qlco]|["Serious"-tx-6-"SERIOUS"-adj-0,"Serious"-tx-5-"SERIOUS"-adj-0]|TX|1768/7;1354/7|
00000000|MMI|5.64|80%|C3842583|[fndg]|["80%"-tx-3-"80"-integer-0]|TX|[627/2],[672/2]|
00000000|MMI|5.64|30%|C3842588|[fndg]|["30%"-tx-6-"30"-integer-0,"30%"-tx-3-"30"-integer-0]|TX|1461/2;814/2|
00000000|MMI|5.63|/40|C0439509|[tmco]|["/40"-tx-21-"40s"-noun-0,"/40"-tx-6-"40"-integer-0]|TX|3564/3;1659/2|
00000000|MMI|5.63|40%|C3842587|[qnco]|["40%"-tx-21-"40s"-noun-0,"40%"-tx-6-"40"-integer-0]|TX|3564/3;1659/2|
00000000|MMI|5.62|Further|C1517331|[spco]|["Further"-tx-16-"further"-adj-0,"Further"-tx-10-"further"-adj-0]|TX|3263/7;2985/7|
00000000|MMI|5.60|100%|C3817553|[qnco]|["100%"-tx-3-"100"-integer-0]|TX|[592/3],[701/3]|
00000000|MMI|5.60|milliliter|C0439242|[qnco]|["MILLILITER"-tx-3-"MILLILITERS"-noun-0,"MILLILITER"-tx-3-"milliliters"-noun-0]|TX|758/11;817/11|
00000000|MMI|5.58|Numerous|C0439064|[qnco]|["MULTIPLE"-tx-9-"multiple"-adj-0,"MULTIPLE"-tx-8-"multiple"-adj-0]|TX|2903/8;2705/8|
00000000|MMI|5.43|Woman|C0043210|[popg]|["WOMAN"-tx-8-"woman"-noun-0]|TX|2686/5|M01.975
00000000|MMI|4.21|3+ Answer to Question|C3838680|[fndg]|["3+"-tx-26-"3"-integer-0]|TX|3815/1|
00000000|MMI|4.21|3+ Score|C2827736|[qnco]|["3+"-tx-26-"3"-integer-0]|TX|3815/1|
00000000|MMI|4.21|3+ Score, WHO|C2981702|[clas]|["3+"-tx-26-"3"-integer-0]|TX|3815/1|
00000000|MMI|4.21|55|C0450382|[inpr]|["55"-tx-3-"55"-integer-0]|TX|926/2|
00000000|MMI|4.21|<3 (qualifier value)|C0439086|[qnco]|["<3"-tx-26-"3"-integer-0]|TX|3815/1|
00000000|MMI|4.21|ActInformationPrivacyReason <operations>|C3244305|[ftcn]|["operations"-tx-8-"OPERATIONS"-noun-0]|TX|2558/10|
00000000|MMI|4.21|Affecting|C0392760|[ftcn]|["Affecting"-tx-8-"affecting"-verb-0]|TX|2262/9|
00000000|MMI|4.21|Arylsulfatase A, human|C3853627|[aapp,enzy]|["ASA"-tx-15-"ASA"-noun-0]|TX|3223/3|
00000000|MMI|4.21|Basal Diet|C2983588|[food]|["DIET"-tx-7-"DIET"-noun-0]|TX|1868/4|
00000000|MMI|4.21|Biomedical Monitors|C0181904|[medd]|["Monitor"-tx-7-"monitor"-verb-0]|TX|1860/7|
00000000|MMI|4.21|Bounded by|C0332297|[spco]|["BB"-tx-15-"BB"-noun-0]|TX|3248/2|
00000000|MMI|4.21|Call (Instruction)|C1947967|[ftcn]|["Call"-tx-3-"call"-verb-0]|TX|933/4|
00000000|MMI|4.21|Cardiovascular System Findings Domain|C3538987|[idcn]|["CV"-tx-13-"CV"-noun-0]|TX|3099/2|
00000000|MMI|4.21|Cataract surgery|C2939459|[topp]|["Cataract surgery"-tx-8-"cataract surgery"-noun-0]|TX|2446/16|
00000000|MMI|4.21|Cataract surgery specialty (qualifier value)|C2004600|[hlca]|["Cataract surgery"-tx-8-"cataract surgery"-noun-0]|TX|2446/16|
00000000|MMI|4.21|Complication|C0009566|[patf]|["Complications"-tx-8-"Complications"-noun-0]|TX|2246/13|
00000000|MMI|4.21|Congestive heart failure|C0018802|[dsyn]|["CHF"-tx-8-"CHF"-noun-0]|TX|2720/3|
00000000|MMI|4.21|Contraindicated|C1444657|[fndg]|["Contraindicated"-tx-27-"contraindicated"-verb-1]|TX|3886/15|
00000000|MMI|4.21|Decision|C0679006|[menp]|["Call"-tx-3-"call"-verb-0]|TX|933/4|
00000000|MMI|4.21|Diet (animal life circumstance)|C3668949|[food]|["Diet"-tx-7-"DIET"-noun-0]|TX|1868/4|
00000000|MMI|4.21|Discharge date|C2361123|[tmco]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|134/14|
00000000|MMI|4.21|Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2361122|[clna]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|134/14|
00000000|MMI|4.21|Disposition|C0743223|[idcn]|["Disposition"-tx-3-"DISPOSITION"-noun-0]|TX|415/11|
00000000|MMI|4.21|Disposition Domain|C1705555|[inpr]|["Disposition"-tx-3-"DISPOSITION"-noun-0]|TX|415/11|
00000000|MMI|4.21|Doctor of Philosophy|C1512022|[inpr]|["Ph.D."-tx-5-"PH.D"-noun-0]|TX|1295/4|
00000000|MMI|4.21|Gently|C1638411|[qlco]|["Gently"-tx-18-"gently"-adv-0]|TX|3374/6|
00000000|MMI|4.21|HL7PublishingSubSection <operations>|C3244306|[inpr]|["operations"-tx-8-"OPERATIONS"-noun-0]|TX|2558/10|
00000000|MMI|4.21|Hypertension Adverse Event|C1963138|[fndg]|["Hypertension"-tx-8-"hypertension"-noun-0]|TX|2293/12|
00000000|MMI|4.21|Impaired|C0221099|[ftcn]|["Impaired"-tx-22-"impaired"-verb-0]|TX|3719/8|
00000000|MMI|4.21|Interventional procedure|C0184661|[topp]|["PROCEDURES"-tx-8-"PROCEDURES"-noun-0]|TX|2573/10|
00000000|MMI|4.21|Involvement with|C1314939|[ftcn]|["Affecting"-tx-8-"affecting"-verb-0]|TX|2262/9|
00000000|MMI|4.21|Make - Instruction Imperative|C1881534|[ftcn]|["Make"-tx-31-"make"-verb-0]|TX|4203/4|
00000000|MMI|4.21|Monitor Device Component|C1704646|[mnob]|["Monitor"-tx-7-"monitor"-verb-0]|TX|1860/7|
00000000|MMI|4.21|Monitor, occupation|C1521743|[prog]|["Monitor"-tx-7-"monitor"-verb-0]|TX|1860/7|
00000000|MMI|4.21|Monitoring Device|C0596972|[medd]|["Monitor"-tx-7-"monitor"-verb-0]|TX|1860/7|
00000000|MMI|4.21|Not Applicable|C1272460|[qlco]|["NOT APPLICABLE"-tx-2-"Not Applicable"-adj-0]|TX|311/14|
00000000|MMI|4.21|On admission|C0457453|[tmco]|["On admission"-tx-17-"on admission"-adj-0]|TX|3355/12|
00000000|MMI|4.21|Package Type Not Applicable|C4049872|[ftcn]|["Not Applicable"-tx-2-"Not Applicable"-adj-0]|TX|311/14|
00000000|MMI|4.21|Positive|C1446409|[qlco]|["ruled"-tx-13-"Ruled"-verb-0]|TX|3114/5|
00000000|MMI|4.21|Preventive monitoring|C0150369|[hlca]|["monitor"-tx-7-"monitor"-verb-0]|TX|1860/7|
00000000|MMI|4.21|Procedure (set of actions)|C2700391|[acty]|["Procedures"-tx-8-"PROCEDURES"-noun-0]|TX|2573/10|
00000000|MMI|4.21|Psychiatric problem|C1306597|[mobd]|["psych"-tx-24-"Psych"-noun-0]|TX|3733/5|
00000000|MMI|4.21|Pump Device Component|C1706421|[mnob]|["Pump"-tx-17-"Pump"-noun-0]|TX|3324/4|
00000000|MMI|4.21|Rhythm|C0871269|[fndg]|["Rhythm"-tx-19-"Rhythm"-noun-0]|TX|3444/6|
00000000|MMI|4.21|Rhythm Not Otherwise Specified ECG Assessment|C3828331|[inpr]|["Rhythm Not Otherwise Specified"-tx-19-"Rhythm"-noun-0]|TX|3444/6|
00000000|MMI|4.21|S prime|C2603362|[clna]|["S'"-tx-7-"("-noun-0]|TX|1977/1|
00000000|MMI|4.21|Special Diet Therapy|C1519433|[topp]|["DIET"-tx-7-"DIET"-noun-0]|TX|1868/4|
00000000|MMI|4.21|Take|C1515187|[hlca]|["Take"-tx-3-"Take"-verb-0]|TX|975/4|
00000000|MMI|4.21|Therapeutic|C0302350|[ftcn]|["Therapeutic"-tx-4-"THERAPEUTIC"-adj-0]|TX|1168/11|E02
00000000|MMI|4.21|Tube feeding of patient|C0041281|[topp]|["tube feed"-tx-4-"tube feeds"-verb-0]|TX|1103/10|
00000000|MMI|4.21|Worried|C0233481|[fndg]|["Worry"-tx-22-"worry"-noun-0]|TX|3680/5|
00000000|MMI|4.21|atorvastatin|C0286651|[orch,phsu]|["ATORVASTATIN"-tx-6-"ATORVASTATIN"-noun-0]|TX|1681/12|
00000000|MMI|4.21|event cycle|C1511572|[tmco]|["Cycle"-tx-4-"cycle"-noun-0]|TX|1123/5|
00000000|MMI|4.21|per second|C0565930|[qnco]|["/s"-tx-7-"("-noun-0]|TX|1977/1|
00000000|MMI|4.21|pump (device)|C0182537|[medd]|["Pump"-tx-17-"Pump"-noun-0]|TX|3324/4|
00000000|MMI|4.21|rhythmic process (biological)|C1523018|[phsf]|["rhythm"-tx-19-"Rhythm"-noun-0]|TX|3444/6|
00000000|MMI|4.21|therapeutic multivitamins|C0724703|[phsu,vita]|["therapeutic multivitamins"-tx-4-"THERAPEUTIC MULTIVITAMINS"-noun-0]|TX|1182/25|
00000000|MMI|4.21|treatments and procedures|C0237403|[topp]|["treatments procedures"-tx-8-"TREATMENTS/PROCEDURES"-noun-0]|TX|2596/21|
00000000|MMI|3.34|Known allergy|C3845888|[fndg]|["Known allergy"-tx-8-"Known Allergies"-noun-1]|TX|2063/15|
00000000|MMI|3.10|Bradycardia by ECG Finding|C3812171|[fndg]|["BRADYCARDIA"-tx-21-"bradycardic"-adj-0]|TX|3547/11|
00000000|MMI|3.05|Additional comments|C1830770|[fndg]|["Additional comments"-tx-31-"ADDITIONAL COMMENTS"-noun-0]|TX|4135/19|
00000000|MMI|3.05|Fluid overload|C0546817|[dsyn]|["VOLUME OVERLOAD"-tx-8-"volume overload"-noun-0]|TX|2847/15|
00000000|MMI|2.99|% volume (qualifier value)|C1690016|[qlco]|["% volume"-tx-17-"volume"-noun-0]|TX|3337/6|
00000000|MMI|2.99|ALYREF gene|C1425988|[gngm]|["REF"-tx-5-"ref"-noun-0]|TX|1325/3|
00000000|MMI|2.99|ActInformationPrivacyReason <service>|C3245478|[idcn]|["service"-tx-2-"Service"-noun-0]|TX|241/7|
00000000|MMI|2.99|At|C1516077|[spco]|["At"-tx-8-"at"-adj-0]|TX|2885/2|
00000000|MMI|2.99|Attending (action)|C1999232|[ftcn]|["attending"-tx-2-"Attending"-noun-0]|TX|373/9|
00000000|MMI|2.99|Attending (provider role)|C1547429|[prog]|["Attending"-tx-2-"Attending"-noun-0]|TX|373/9|
00000000|MMI|2.99|GATM wt Allele|C4049625|[gngm]|["AT"-tx-8-"at"-adj-0]|TX|2885/2|
00000000|MMI|2.99|Lipids|C0023779|[orch]|["Lipids"-tx-8-"lipids"-noun-0]|TX|2347/6|D10
00000000|MMI|2.99|M NOS ANTIBODY|C0369637|[aapp,imft]|["M NOS"-tx-33-"M"-noun-0]|TX|4371/1|
00000000|MMI|2.99|M+ (tumor staging)|C0441923|[inpr]|["M+"-tx-33-"M"-noun-0]|TX|4371/1|
00000000|MMI|2.99|Services|C0557854|[ocac]|["Service"-tx-2-"Service"-noun-0]|TX|241/7|
00000000|MMI|2.99|Software Service|C2825316|[mnob]|["Service"-tx-2-"Service"-noun-0]|TX|241/7|
00000000|MMI|2.99|Volume|C0449468|[qnco]|["*Volume"-tx-17-"volume"-noun-0]|TX|3337/6|
00000000|MMI|2.99|Volume (publication)|C1705102|[inpr]|["Volume"-tx-17-"volume"-noun-0]|TX|3337/6|
00000000|MMI|2.99|Volume Measurement|C2700258|[lbpr]|["Volume"-tx-17-"volume"-noun-0]|TX|3337/6|
00000000|MMI|2.98|Principal Diagnosis:-:Point in time:^Patient:-|C2598194|[clna]|["Principal Diagnosis"-tx-8-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|2107/9,2127/9|
00000000|MMI|2.98|Principal diagnosis|C0332137|[qlco]|["Principal Diagnosis"-tx-8-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|2107/9,2127/9|
00000000|MMI|2.96|Medication.discharge|C0806915|[fndg]|["Discharge medications"-tx-3-"DISCHARGE MEDICATIONS"-noun-0]|TX|453/21|
00000000|MMI|2.96|Report status|C0586177|[fndg]|["Report status"-tx-1-"Report Status"-noun-0]|TX|119/13|
00000000|MMI|2.96|discharge diagnosis|C1555319|[fndg]|["Discharge diagnosis"-tx-8-"DISCHARGE DIAGNOSIS"-noun-1]|TX|2117/19|
00000000|MMI|2.96|renal drug clearance|C0678763|[orgf]|["renal drug clearance"-tx-22-"renal clearance drug"-noun-0]|TX|3691/15,3710/4|
00000000|MMI|2.96|Entered|C1521975|[qlco]|["Entered"-tx-33-"ENTERED"-verb-0]|TX|4344/7|
00000000|MMI|2.95|+5|C0728893|[qnco]|["+5"-tx-1-"5"-fraction-0]|TX|150/1|
00000000|MMI|2.95|>5|C0439084|[qnco]|[">5"-tx-1-"5"-fraction-0]|TX|150/1|
00000000|MMI|2.95|Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2598112|[clna]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|92/14|
00000000|MMI|2.95|CR2 wt Allele|C3539604|[gngm]|["CR"-tx-22-"Cr"-noun-0]|TX|3667/2|
00000000|MMI|2.95|Creatinine measurement|C0201975|[lbpr]|["Cr"-tx-22-"Cr"-noun-0]|TX|3667/2|
00000000|MMI|2.95|Date of admission|C1302393|[tmco]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|92/14|
00000000|MMI|2.95|MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME|C3280240|[dsyn]|["MEDS"-tx-25-"meds"-noun-0]|TX|3778/4|
00000000|MMI|2.95|Stratification|C1514983|[resa]|["Stratification"-tx-16-"stratification"-noun-0]|TX|3276/14|
00000000|MMI|2.95|Titer|C0475208|[qnco]|["Titer"-tx-8-"titers"-noun-0]|TX|2421/6|
00000000|MMI|2.93|*Activity (kind of quantity)|C1561536|[idcn]|["*Activity"-tx-7-"ACTIVITY"-noun-0]|TX|1925/8|
00000000|MMI|2.93|Active|C0205177|[ftcn]|["Activity"-tx-7-"ACTIVITY"-noun-0]|TX|1925/8|
00000000|MMI|2.93|Activities|C0441655|[acty]|["ACTIVITY"-tx-7-"ACTIVITY"-noun-0]|TX|1925/8|
00000000|MMI|2.93|Activity (animal life circumstance)|C3668946|[fndg]|["Activity"-tx-7-"ACTIVITY"-noun-0]|TX|1925/8|
00000000|MMI|2.93|FDA Establishment Activity Terminology|C4049939|[inpr]|["ACTIVITY"-tx-7-"ACTIVITY"-noun-0]|TX|1925/8|
00000000|MMI|2.93|Percent Activity|C0439167|[qnco]|["% Activity"-tx-7-"ACTIVITY"-noun-0]|TX|1925/8|
00000000|MMI|2.93|Physical Activity Measurement|C4049938|[lbpr]|["ACTIVITY"-tx-7-"ACTIVITY"-noun-0]|TX|1925/8|
00000000|MMI|2.93|Planned|C1301732|[ftcn]|["Plan"-tx-31-"PLAN"-noun-0]|TX|4190/4|
00000000|MMI|2.93|Treatment Plan|C0599880|[inpr]|["Plan"-tx-31-"PLAN"-noun-0]|TX|4190/4|
00000000|MMI|2.92|Lobular Neoplasia|C0861352|[neop]|["LN"-tx-1-"Ln"-noun-0]|TX|229/2|
00000000|MMI|2.92|MLPH gene|C1428884|[gngm]|["ln"-tx-1-"Ln"-noun-0]|TX|229/2|
00000000|MMI|2.92|late nucleophagy|C3714709|[celf]|["LN"-tx-1-"Ln"-noun-0]|TX|229/2|
00000000|MMI|2.92|60%|C3842585|[fndg]|["60%"-tx-21-"60s"-noun-0]|TX|3568/3|
00000000|MMI|2.92|Pyrexia of unknown origin (excl puerperal)|C0856281|[sosy]|["puo"-tx-1-"PUO"-noun-0]|TX|12/3|
00000000|MMI|2.91|Asymptomatic|C0231221|[fndg]|["Asymptomatic"-tx-21-"asymptomatic"-adj-0]|TX|3578/12|
00000000|MMI|2.91|End|C0444930|[spco]|["End"-tx-35-"END"-noun-0]|TX|4409/3|
00000000|MMI|2.91|Endocrine System Findings Domain|C3538926|[idcn]|["ED"-tx-8-"ED"-noun-0]|TX|2817/2|
00000000|MMI|2.91|Ischemic Change|C2826576|[fndg]|["Ischemic Change"-tx-14-"ischemic changes"-noun-1]|TX|3158/16|
00000000|MMI|2.91|Responsible to|C1273518|[fndg]|["Responsible"-tx-8-"Responsible"-adj-1]|TX|2138/11|
00000000|MMI|2.91|Stop (qualifier value)|C2746065|[tmco]|["End"-tx-35-"END"-noun-0]|TX|4409/3|
00000000|MMI|2.91|6/4|C0442748|[fndg]|["6/4"-tx-8-"6 4"-fraction-0]|TX|2823/1,2828/1|
00000000|MMI|2.91|Electrocardiographic changes|C0855329|[fndg]|["ekg change"-tx-14-"changes EKG"-noun-1]|TX|3167/7,3178/3|
00000000|MMI|2.90|Cardiac enzymes|C0443763|[aapp,enzy]|["Cardiac enzymes"-tx-13-"cardiac enzymes"-noun-0]|TX|3137/15|
00000000|MMI|2.90|Cardiac - anatomy qualifier|C1522601|[spco]|["Cardiac"-tx-15-"cardiac"-adj-0]|TX|3206/7|
00000000|MMI|2.90|Clinical act of insertion|C0441587|[hlca]|["Placement"-tx-11-"placement"-noun-0]|TX|3069/9|
00000000|MMI|2.90|Conditional|C1701901|[qlco]|["Contingent"-tx-2-"CONTINGENT"-noun-0]|TX|295/10|
00000000|MMI|2.90|Empty (qualifier)|C1880497|[qlco]|["Empty"-tx-3-"empty"-adj-0]|TX|1010/5|
00000000|MMI|2.90|Entire stomach|C1278920|[bpoc]|["Stomach"-tx-3-"stomach"-noun-0]|TX|1016/7|
00000000|MMI|2.90|Gastric Tissue|C1517454|[tisu]|["STOMACH"-tx-3-"stomach"-noun-0]|TX|1016/7|
00000000|MMI|2.90|Geographic state|C1301808|[geoa]|["stated"-tx-16-"stated"-adj-0]|TX|3308/6|
00000000|MMI|2.90|Maintaining (action)|C1314677|[ftcn]|["Maintained"-tx-15-"maintained"-verb-0]|TX|3192/10|
00000000|MMI|2.90|Performed|C0884358|[ftcn]|["Performed"-tx-16-"performed"-verb-0]|TX|3295/9|
00000000|MMI|2.90|Placement|C1524072|[qlco]|["Placement"-tx-11-"placement"-noun-0]|TX|3069/9|
00000000|MMI|2.90|Placement action|C1533810|[hlca]|["Placement"-tx-11-"placement"-noun-0]|TX|3069/9|
00000000|MMI|2.90|Regimen - CHV concept|C2945654|[inpr]|["regimen"-tx-15-"regimen"-noun-0]|TX|3214/7|
00000000|MMI|2.90|State|C1442792|[ftcn]|["Stated"-tx-16-"stated"-adj-0]|TX|3308/6|
00000000|MMI|2.90|Stomach structure|C3714551|[bpoc]|["Stomach"-tx-3-"stomach"-noun-0]|TX|1016/7|
00000000|MMI|2.89|23|C0450348|[qnco]|["23"-tx-4-"23"-fraction-0]|TX|1259/2|
00000000|MMI|2.89|Discussion (procedure)|C0557061|[topp]|["discussions"-tx-29-"discussions"-noun-0]|TX|3995/11|
00000000|MMI|2.88|Back structure, excluding neck|C1995000|[blor]|["Back, NOS"-tx-18-"back"-adj-0]|TX|3408/4|
00000000|MMI|2.88|Back structure, including back of neck|C0460009|[blor]|["Back"-tx-18-"back"-adj-0]|TX|3408/4|
00000000|MMI|2.88|Curriculum Vitae|C1880201|[inpr]|["Resume"-tx-8-"RESUME"-noun-0]|TX|2645/6|
00000000|MMI|2.88|Dorsal|C0205095|[spco]|["BACK"-tx-18-"back"-adj-0]|TX|3408/4|
00000000|MMI|2.88|Resume - Remote control command|C1550028|[idcn]|["Resume"-tx-8-"RESUME"-noun-0]|TX|2645/6|
00000000|MMI|2.88|Total Amyloid Precursor Protein Measurement|C3887695|[lbpr]|["APPT"-tx-31-"appt"-noun-0]|TX|4218/4|
00000000|MMI|2.88|Used by|C1273517|[fndg]|["used"-tx-2-"USED"-verb-1]|TX|344/4|
00000000|MMI|2.88|resume - DataOperation|C3242342|[ftcn]|["resume"-tx-8-"RESUME"-noun-0]|TX|2645/6|
00000000|MMI|2.88|Out (direction)|C0439787|[spco]|["Out"-tx-13-"out"-adv-0]|TX|3120/3|
00000000|MMI|2.88|Removed|C0849355|[qlco]|["Out"-tx-13-"out"-adv-0]|TX|3120/3|
00000000|MMI|2.88|Set scale|C1442518|[ftcn]|["Set"-tx-13-"sets"-noun-0]|TX|3129/4|
00000000|MMI|2.88|set (group)|C1705195|[cnce]|["Set"-tx-13-"sets"-noun-0]|TX|3129/4|
00000000|MMI|2.87|Issue (document)|C1706387|[inpr]|["Issue"-tx-11-"issues"-noun-0]|TX|3079/6|
00000000|MMI|2.87|Problem|C0033213|[fndg]|["Issue"-tx-11-"issues"-noun-0]|TX|3079/6|
00000000|MMI|2.87|Doctor of Chiropractic|C1512015|[inpr]|["D.C."-tx-2-"D/C"-noun-0]|TX|331/3|
00000000|MMI|2.87|Maalox|C0065461|[inch,phsu]|["Maalox"-tx-3-"MAALOX"-noun-0]|TX|728/6|
00000000|MMI|2.84|Aspirin 325 MG|C0992015|[clnd]|["Acetylsalicylic Acid 325 MG"-tx-3-"ACETYLSALICYLIC ACID 325 MG"-noun-0]|TX|476/27|
00000000|MMI|2.84|Causing|C0678227|[ftcn]|["Causing"-tx-8-"Causing"-adj-0]|TX|2166/7|
00000000|MMI|2.84|Elevated|C3163633|[qlco]|["Elevated"-tx-8-"elevated"-adj-0]|TX|2338/8|
00000000|MMI|2.84|Gentle|C0720654|[orch,phsu]|["Gentle"-tx-11-"gentle"-adj-0]|TX|3038/6|
00000000|MMI|2.84|High|C0205250|[qlco]|["Elevated"-tx-8-"elevated"-adj-0]|TX|2338/8|
00000000|MMI|2.84|MILDLY|C0750532|[idcn]|["MILDLY"-tx-17-"Mildly"-adv-0]|TX|3330/6|
00000000|MMI|2.84|South|C1710133|[spco]|["South"-tx-2-"South"-noun-0]|TX|235/5|
00000000|MMI|2.84|T prime|C2603360|[clna]|["T'"-tx-18-"t"-noun-0]|TX|3394/1|
00000000|MMI|2.84|Yes (indicator)|C1705108|[cnce]|["YES"-tx-2-"YES"-noun-0]|TX|369/3|
00000000|MMI|2.84|Yes - Yes/no indicator|C1549445|[idcn]|["Yes"-tx-2-"YES"-noun-0]|TX|369/3|
00000000|MMI|2.84|dictated - DocumentCompletion|C1609990|[idcn]|["Dictated"-tx-33-"dictated"-adj-0]|TX|4327/8|
00000000|MMI|2.84|dictated - ParticipationMode|C1548384|[ftcn]|["dictated"-tx-33-"dictated"-adj-0]|TX|4327/8|
00000000|MMI|2.83|Chest pain:Finding:Point in time:^Patient:Ordinal|C2926613|[clna]|["Chest pain"-tx-8-"chest pain"-noun-0]|TX|2096/10|
00000000|MMI|2.83|history of - * (non-specific)|C0455483|[fndg]|["h o"-tx-8-"h/o"-noun-0]|TX|2308/3|
00000000|MMI|2.82|90%|C3842582|[fndg]|["90%"-tx-3-"90"-integer-0]|TX|917/2|
00000000|MMI|2.82|<90|C0439087|[qnco]|["<90"-tx-3-"90"-integer-0]|TX|917/2|
00000000|MMI|2.82|>90|C0439083|[qnco]|[">90"-tx-3-"90"-integer-0]|TX|917/2|
00000000|MMI|2.82|Administration procedure|C1533734|[topp]|["Treatment"-tx-8-"Treatment"-noun-0]|TX|2272/9|
00000000|MMI|2.82|Biomaterial Treatment|C1705169|[cnce]|["Treatment"-tx-8-"Treatment"-noun-0]|TX|2272/9|
00000000|MMI|2.82|Treating|C1522326|[ftcn]|["Treatment"-tx-8-"Treatment"-noun-0]|TX|2272/9|
00000000|MMI|2.82|Treatment Epoch|C3538994|[resa]|["TREATMENT"-tx-8-"Treatment"-noun-0]|TX|2272/9|
00000000|MMI|2.82|treatment - ActInformationManagementReason|C3887704|[hlca]|["treatment"-tx-8-"Treatment"-noun-0]|TX|2272/9|
00000000|MMI|2.82|30 Minutes|C1442458|[tmco]|["1/2 hr"-tx-4-"1 hr 2"-noun-0]|TX|1136/4,1151/1|
00000000|MMI|2.81|Patient Condition Code - Stable|C1547311|[inpr]|["Stable"-tx-31-"Stable"-adj-0]|TX|4177/6|
00000000|MMI|2.81|Sodium Cation|C0597484|[elii]|["Sodium+"-tx-7-"Sodium"-noun-0]|TX|1918/6|
00000000|MMI|2.81|Sodium Drug Class|C3714642|[phsu]|["SODIUM"-tx-7-"Sodium"-noun-0]|TX|1918/6|
00000000|MMI|2.81|Sodium supplements|C3541959|[phsu]|["Sodium"-tx-7-"Sodium"-noun-0]|TX|1918/6|
00000000|MMI|2.81|Stable status|C0205360|[qlco]|["STABLE"-tx-31-"Stable"-adj-0]|TX|4177/6|
00000000|MMI|2.81|Tablet Dosing Unit|C1705223|[qnco]|["Tab"-tx-4-"TAB"-noun-0]|TX|1212/3|
00000000|MMI|2.81|gram|C0439208|[qnco]|["GRAM"-tx-7-"gram"-noun-0]|TX|1913/4|
00000000|MMI|2.81|FBL gene|C1414538|[gngm]|["FIB"-tx-8-"fib"-noun-0]|TX|2314/3|
00000000|MMI|2.81|HORNS IN SHEEP|C1832110|[fndg]|["HO"-tx-3-"ho"-noun-0]|TX|938/2|
00000000|MMI|2.81|Healthcare Encounters Domain|C3889614|[inpr]|["HO"-tx-3-"ho"-noun-0]|TX|938/2|
00000000|MMI|2.81|Primary|C0205225|[qlco]|["Principal"-tx-8-"PRINCIPAL"-adj-0]|TX|2107/9|
00000000|MMI|2.81|Teaching principal|C0401925|[prog]|["Principal"-tx-8-"PRINCIPAL"-adj-0]|TX|2107/9|
00000000|MMI|2.81|20%|C3842589|[fndg]|["20%"-tx-6-"20"-integer-0]|TX|1696/2|
00000000|MMI|2.81|Alert|C3665546|[ftcn]|["Alert"-tx-6-"Alert"-noun-0]|TX|1708/5|
00000000|MMI|2.81|Alert:Type:Point in time:^Patient:Nominal|C3669039|[clna]|["Alert"-tx-6-"Alert"-noun-0]|TX|1708/5|
00000000|MMI|2.81|Consciousness clear|C0239110|[fndg]|["ALERT"-tx-6-"Alert"-noun-0]|TX|1708/5|
00000000|MMI|2.81|Diagnostic interview schedule|C0451119|[inpr]|["DIS"-tx-1-"DIS"-noun-0]|TX|86/3|
00000000|MMI|2.80|Cholesterol measurement test|C0201950|[lbpr]|["CHOL"-tx-7-"chol"-noun-0]|TX|1886/4|
00000000|MMI|2.80|Constipation Adverse Event|C1963087|[fndg]|["Constipation"-tx-3-"Constipation"-noun-0]|TX|839/12|
00000000|MMI|2.80|House (environment)|C2003847|[mnob]|["House"-tx-7-"House"-noun-0]|TX|1874/5|
00000000|MMI|2.80|SAT1 protein, human|C2744672|[aapp,enzy]|["SAT"-tx-7-"sat"-noun-0]|TX|1895/3|
00000000|MMI|2.80|SAT1 wt Allele|C1705827|[gngm]|["SAT"-tx-7-"sat"-noun-0]|TX|1895/3|
00000000|MMI|2.80|Hospital course|C0489547|[fndg]|["Hospital course"-tx-8-"HOSPITAL COURSE"-noun-1]|TX|2655/15|
00000000|MMI|2.80|Hospital course:Finding:Point in time:^Patient:Narrative|C0488549|[clna]|["Hospital course"-tx-8-"HOSPITAL COURSE"-noun-0]|TX|2655/15|
00000000|MMI|2.80|Room of building - Study|C0557651|[mnob]|["Study"-tx-8-"Study"-noun-0]|TX|2156/5|
00000000|MMI|2.80|Sinus rhythm|C0232201|[fndg]|["SINUS RHYTHM"-tx-19-"sinus rhythm"-noun-0]|TX|3492/12|
00000000|MMI|2.80|Study|C2603343|[resa]|["Study"-tx-8-"Study"-noun-0]|TX|2156/5|
00000000|MMI|2.79|2/5|C0450346|[qnco]|["2 5"-tx-6-"2.5"-real_number-0]|TX|1577/3|
00000000|MMI|2.79|ANTICOAGULATION (finding)|C2919015|[fndg]|["ANTICOAGULATION"-tx-20-"anticoagulation"-noun-1]|TX|3525/15|
00000000|MMI|2.79|Anticoagulation Therapy|C0003281|[topp]|["anticoagulation"-tx-20-"anticoagulation"-noun-0]|TX|3525/15|
00000000|MMI|2.79|Condoms, Unspecified|C0677582|[medd]|["Prophylactic"-tx-27-"prophylactic"-adj-0]|TX|3840/12|
00000000|MMI|2.79|Decreased Coagulation Activity [PE]|C3537050|[phsf]|["Anticoagulation"-tx-20-"anticoagulation"-noun-1]|TX|3525/15|
00000000|MMI|2.79|Drugs used in migraine prophylaxis|C0355642|[phsu]|["Prophylactic"-tx-27-"prophylactic"-adj-0]|TX|3840/12|
00000000|MMI|2.79|Infusion pump Alert priority PM|C4049155|[fndg]|["PM"-tx-2-"PM"-adj-0]|TX|292/2|
00000000|MMI|2.79|Negative Regulation of Coagulation|C2917212|[phsf]|["Anticoagulation"-tx-20-"anticoagulation"-noun-1]|TX|3525/15|
00000000|MMI|2.79|Prophylactic behavior|C0445202|[ftcn]|["Prophylactic"-tx-27-"prophylactic"-adj-0]|TX|3840/12|
00000000|MMI|2.79|Extensive|C0205231|[qlco]|["Extensive"-tx-29-"extensive"-adj-0]|TX|3985/9|
00000000|MMI|2.79|Family (taxonomic)|C1704727|[cnce]|["Family"-tx-29-"family"-noun-0]|TX|4012/6|
00000000|MMI|2.79|Ischemic|C0475224|[ftcn]|["Ischemic"-tx-14-"ischemic"-adj-0]|TX|3158/8|
00000000|MMI|2.78|Frames Per Second|C3714799|[tmco]|["F/s"-tx-8-"89 F"-noun-0]|TX|2672/4|
00000000|MMI|2.78|Behavior Rating Inventory of Executive Function|C4050216|[inpr]|["BRIEF"-tx-8-"BRIEF"-adj-0]|TX|2639/5|
00000000|MMI|2.78|Brief|C1879313|[tmco]|["Brief"-tx-8-"BRIEF"-adj-0]|TX|2639/5|
00000000|MMI|2.78|Lisinopril 30 MG|C0987220|[clnd]|["Lisinopril 30 MG"-tx-3-"LISINOPRIL MG 30"-noun-0]|TX|705/10,719/2,755/2|
00000000|MMI|2.78|Shortened|C1282927|[qlco]|["brief"-tx-8-"BRIEF"-adj-0]|TX|2639/5|
00000000|MMI|2.78|Identical|C0205280|[qlco]|["Identical"-tx-9-"identical"-adj-0]|TX|2912/9|
00000000|MMI|2.78|Past|C1444637|[tmco]|["Past"-tx-9-"past"-adj-0]|TX|2942/4|
00000000|MMI|2.78|per year|C0439508|[tmco]|["/Year"-tx-9-"year"-noun-0]|TX|2947/4|
00000000|MMI|2.78|year|C0439234|[tmco]|["YEAR"-tx-9-"year"-noun-0]|TX|2947/4|
00000000|MMI|2.78|Peritoneal Cancer Index|C4049621|[inpr]|["PCI"-tx-8-"PCI"-noun-0]|TX|2714/3|
00000000|MMI|2.77|50%|C3842586|[fndg]|["50%"-tx-3-"50"-integer-0]|TX|716/2|
00000000|MMI|2.77|<50|C3843766|[fndg]|["<50"-tx-3-"50"-integer-0]|TX|716/2|
00000000|MMI|2.77|